How is one of the world’s largest pharmaceutical companies promoting sustainability throughout its extensive supply chain?

With more than $85 billion in revenue, Johnson & Johnson is among the world’s top pharmaceutical companies. And with that industry dominance comes a slew of challenges relating to supply chain efficiency, compliance and sustainability. On this episode, we discuss J&J’s strategy for meeting those goals with Kathy Wengel, the company’s executive vice president and chief technical operations and risk officer. She describes how J&J works with multiple tiers of suppliers to ensure that all of its supply chain partners are undertaking necessary environmental and social improvements. The trick lies in moving forward simultaneously on multiple fronts, including regulatory compliance, productivity, efficiency, sustainability and risk mitigation. All fall under Wengel’s long list of day-to-day responsibilities. And in the world of pharma today, there’s no allowance for coming up short in any of them. Hosted by Bob Bowman, Editor-in-Chief of SupplyChainBrain.

Show notes:

J&H’s 2023 Health for Humanity Report.